| Literature DB >> 29675322 |
Thomas Pauwelyn1,2, Richard Stahl2, Lakyn Mayo3, Xuan Zheng2, Andy Lambrechts2, Stefan Janssens4, Liesbet Lagae1,2, Veerle Reumers2, Dries Braeken2.
Abstract
The high rate of drug attrition caused by cardiotoxicity is a major challenge for drug development. Here, we developed a reflective lens-free imaging (RLFI) approach to non-invasively record in vitro cell deformation in cardiac monolayers with high temporal (169 fps) and non-reconstructed spatial resolution (352 µm) over a field-of-view of maximally 57 mm2. The method is compatible with opaque surfaces and silicon-based devices. Further, we demonstrated that the system can detect the impairment of both contractility and fast excitation waves in cardiac monolayers. Additionally, the RLFI device was implemented on a CMOS-based microelectrode array to retrieve multi-parametric information of cardiac cells, thereby offering more in-depth analysis of drug-induced (cardiomyopathic) effects for preclinical cardiotoxicity screening applications.Entities:
Keywords: (170.2655) Functional monitoring and imaging; (170.3880) Medical and biological imaging
Year: 2018 PMID: 29675322 PMCID: PMC5905926 DOI: 10.1364/BOE.9.001827
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732